Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extension Study of Laquinimod in Relapsing MS
NCT00988052Phase 3Terminated
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Nov 2009
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 23
01
Overview
A Phase 3 trial of laquinimod in multiple sclerosis (MS), sponsored by Teva Pharmaceutical Industries Ltd.. Started Nov 2009; status: terminated.
02
Drugs
laquinimod
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT00988052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00988052.